Current Cardiology Reports

Article	Citations
Promise and Perils of Telehealth in the Current Era	69
Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction	63
Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19	62
Mechanisms and Treatment of Dyslipidemia in Diabetes	57
Management of Arrhythmias Associated with COVID-19	53
Pericardial Diseases in COVID19: a Contemporary Review	46
Cardiac Rehabilitation: Under-Utilized Globally	44
Complications Following MitraClip Implantation	44
Familial Hypercholesterolemia: Global Burden and Approaches	43
Racial and Ethnic Disparities in Hypertension: Barriers and Opportunities to Improve Blood Pressure Control	42
Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors	41
18F-FDG PET/CT in Infective Endocarditis: Indications and Approaches for Standardization	41
State-of-the-Art of Endomyocardial Biopsy on Acute Myocarditis and Chronic Inflammatory Cardiomyopathy	40
Wnt Signaling in Heart Development and Regeneration	38
Home Monitoring of Cardiac Devices in the Era of COVID-19	38
Immunotherapy-Associated Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy: Diagnostic and Management Challenges and Strategies	36
Remote monitoring and telemedicine in heart failure: implementation and benefits	35
5-FU Cardiotoxicity: Vasospasm, Myocarditis, and Sudden Death	35
Associations of Glycemic Index and Glycemic Load with Cardiovascular Disease: Updated Evidence from Meta-analysis and Cohort Studies	34
Improving Quality of Life in Heart Failure	34
Loneliness and Risk for Cardiovascular Disease: Mechanisms and Future Directions	32
Metabolic Syndrome and Cognitive Function	30
How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?	29
COVID-19 and Cardiovascular Disease: a Global Perspective	29
Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities	26

Epidemiology of Type 1 Diabetes	25
Comprehensive Care Models for Cardiometabolic Disease	25
Long-COVID Syndrome and the Cardiovascular System: A Review of Neurocardiologic Effects on Multiple Systems	23
Vericiguat for Heart Failure with Reduced Ejection Fraction	23
Drug Repurposing: Claiming the Full Benefit from Drug Development	23
Diagnosis and Management of Acute Aortic Syndromes: Dissection, Penetrating Aortic Ulcer, and Intramural Hematoma	23
Relief of Ischemia in Ischemic Cardiomyopathy	23
Clinical Utility of Echocardiographic Strain and Strain Rate Measurements	21
SARS-CoV-2 Myocarditis: Insights Into Incidence, Prognosis, and Therapeutic Implications	21
Myocarditis: Which Role for Genetics?	21
Role of Exercise as a Modulating Factor in Arrhythmogenic Cardiomyopathy	20
Is Sedentary Behavior a Novel Risk Factor for Cardiovascular Disease?	19
Left Bundle Branch Area Pacing: Implant Technique, Definitions, Outcomes, and Complications	19
The Sarcomeric Spring Protein Titin: Biophysical Properties, Molecular Mechanisms, and Genetic Mutations Associated with Heart Failure and Cardiomyopathy	19
Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy	19
New Approaches to Management of Pericardial Effusions	19
The Role of B Cells in Cardiomyopathy and Heart Failure	19
Multimodality Imaging for Cardiac Evaluation in Patients with COVID-19	18
Therapeutic Approach to Calcified Coronary Lesions: Disruptive Technologies	18
Beyond Sarcomeric Hypertrophic Cardiomyopathy: How to Diagnose and Manage Phenocopies	18
Acute Pericarditis: Update	18
Aging Hearts in a Hotter, More Turbulent World: The Impacts of Climate Change on the Cardiovascular Health of Older Adults	18
The Role of Autoantibodies in Arrhythmogenesis	18
Angiography-Based Fractional Flow Reserve: State of the Art	18
Intersection Between Chronic Kidney Disease and Cardiovascular Disease	18
Omega-3 Fatty Acids in Cardiovascular Disease and Diabetes: a Review of Recent Evidence	17
Role of Clinical Genetic Testing in the Management of Aortopathies	17
Update on the Inflammatory Hypothesis of Coronary Artery Disease	17
Sex-Specific Plaque Signature: Uniqueness of Atherosclerosis in Women	17
PCSK9 Inhibitor Wars: How Does Inclisiran Fit in with Current Monoclonal Antibody Inhibitor Therapy? Considerations for Patient Selection	17
Pheochromocytoma and Paraganglioma in Pregnancy: a New Era	17
Cardiovascular Toxicity of Androgen Deprivation Therapy	17
Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease	17
Olive Oil Intake and Cardiovascular Disease Prevention: “Seek and You Shall Find”	16
The Global Impact of Rheumatic Heart Disease	16
Sleep and Circadian Disturbance in Cardiovascular Risk	16
Cusp Overlap Technique: Should It Become the Standard Implantation Technique for Self-expanding Valves?	16
Atrial Fibrillation and Cancer Patients: Mechanisms and Management	16
Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis	16
Mental Stress-Induced Myocardial Ischemia	15
Psychological Distress After Sudden Cardiac Arrest and Its Impact on Recovery	15
Use of Polygenic Risk Scores for Coronary Heart Disease in Ancestrally Diverse Populations	15
COVID’s Impact on Non-communicable Diseases: What We Do Not Know May Hurt Us	14
A Change of Heart: Human Cardiac Tissue Engineering as a Platform for Drug Development	14
The Role of Behavioral Economics in Improving Cardiovascular Health Behaviors and Outcomes	14
Approach to Hypertension in Adolescents and Young Adults	14
Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism	14
Cardiac Manifestations of Post-Acute COVID-19 Infection	14
HIV and Global Cardiovascular Health	14
Sinus Venosus ASDs: Imaging and Percutaneous Closure	14

PET Tracers for Imaging Cardiac Function in Cardio-oncology	14
Cardiovascular Magnetic Resonance Imaging and Heart Failure	14
Stroke Prevention After Cryptogenic Stroke	14
Imaging-Guided Treatment for Cardiac Amyloidosis	14
Physical Activity and Cardiorespiratory Fitness: Vital Signs for Cardiovascular Risk Assessment	13
Athletes and Hypertension	13
A Fishy Topic: VITAL, REDUCE-IT, STRENGTH, and Beyond: Putting Omega-3 Fatty Acids into Practice in 2021	13
COVID-19 Vaccine–Related Myocardial and Pericardial Inflammation	13
Intimate Relationships and Coronary Heart Disease: Implications for Risk, Prevention, and Patient Management	13
Arterial Stiffness and its Impact on Cardiovascular Health	13
Incremental Value of FDG-PET in the Evaluation of Cardiac Masses	13
How Does COVID-19 Affect the Heart?	12
Updates in Cerebral Venous Thrombosis	12
Air Pollution and the Heart: Updated Evidence from Meta-analysis Studies	12
Quantification of Myocardial Mitochondrial Membrane Potential Using PET	12
Hypertrophic Cardiomyopathy: Genetic Testing and Risk Stratification	12
Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits	12
The Role of Depression on Treatment Adherence in Patients with Heart Failure–a Systematic Review of the Literature	12
Cardiac Cell Therapy with Pluripotent Stem Cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do?	12
The Cardiovascular Effects of Electronic Cigarettes	12
Role of Cardiac Fibroblasts in Cardiac Injury and Repair	12
Cardiovascular Disease Amongst Women Treated for Breast Cancer: Traditional Cytotoxic Chemotherapy, Targeted Therapy, and Radiation Therapy	12
Pulsed Field Ablation: a New Paradigm for Catheter Ablation of Arrhythmias	12
Myocardial Fatigue: a Mechano-energetic Concept in Heart Failure	12
Fibroblast and Immune Cell Cross-Talk in Cardiac Fibrosis	11
Cardiac Rehabilitation and Survival for Ischemic Heart Disease	11
Current State and Future Perspectives of Artificial Intelligence for Automated Coronary Angiography Imaging Analysis in Patients with Ischemic Heart Disease	11
The Role of Nurse Practitioners in the Management of Heart Failure Patients and Programs	11
Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk	11
Health Disparities Across the Continuum of ASCVD Risk	11
The Dynamic Role of Cardiac Macrophages in Aging and Disease	11
Contemporary Diagnosis and Management of Patients with MINOCA	11
Monogenic and Polygenic Models of Coronary Artery Disease	11
Donation After Circulatory Death: A New Frontier	11
MRI-Guided Cardiac Catheterization in Congenital Heart Disease: How to Get Started	11
Multimodality Imaging of Constrictive Pericarditis: Pathophysiology and New Concepts	11
3D Printing Approaches to Engineer Cardiac Tissue	11
SAMSON and the Nocebo Effect: Management of Statin Intolerance	11
Evolution and Outcomes of Premature Coronary Artery Disease	10
Autoimmune and Autoinflammatory Pericarditis: Definitions and New Treatments	10
Prognostic Significance of Echocardiographic Measures of Cardiac Remodeling in the Community	10
Recent Advances in Serum Biomarkers for Risk Stratification and Patient Management in Cardio-Oncology	10
Cardiovascular Magnetic Resonance Parametric Mapping Techniques: Clinical Applications and Limitations	10
A Clinician’s Guide to Smartwatch “Interrogation”	10
Contemporary Management of Abdominal Aortic Aneurysms	10
Cardiac Outpatient Care in a Digital Age: Remote Cardiology Clinic Visits in the Era of COVID-19	10
Is Optimism a Protective Factor for Cardiovascular Disease?	10
Role of Telemedicine in Prehospital Stroke Care	10
Is Isolated Diastolic Hypertension an Important Phenotype?	10
Cardiovascular Toxicities Associated with Tyrosine Kinase Inhibitors	10
Current Challenges and Solutions to Tissue Engineering of Large-scale Cardiac Constructs	9
The Riskier Lipid: What Is on the HORIZON for Lipoprotein (a) and Should There Be Lp(a) Screening for All?	9
Should We Be Using Upstream Beta-Blocker Therapy for Acute Myocardial Infarction?	9
Rilonacept (Interleukin-1 Inhibition) for the Treatment of Pericarditis	9
Frailty and Cardiovascular Mortality: A Narrative Review	9
Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD	9
Management of Cardiovascular Health in People with Severe Mental Disorders	9
Autoimmune Pericarditis: Multimodality Imaging	9
Predictors of Microvascular Reperfusion After Myocardial Infarction	9
The Effect of EECP on Ischemic Heart Failure: a Systematic Review	9
AngioVac for Minimally Invasive Removal of Intravascular and Intracardiac Masses: a Systematic Review	9
The Use of Subclinical Atherosclerosis Imaging to Guide Preventive Cardiology Management	9
Heart Transplant Donor Selection Guidelines: Review and Recommendations	9
The Impact of Meteorological Factors and Air Pollutants on Acute Coronary Syndrome	9
Titin-related Cardiomyopathy: Is it a Distinct Disease?	9
Posttraumatic Stress Disorder (PTSD) as a Risk Factor for Cardiovascular Disease: Implications for Future Research and Clinical Care	9
Cardiovascular Outcome Trials with Glucose-Lowering Drugs	9
Diabetes and Cardiovascular Complications: The Epidemics Continue	9
Emerging Genotype–Phenotype Associations in Dilated Cardiomyopathy	9
Acquisition, Processing, and Interpretation of PET 18F-FDG Viability and Inflammation Studies	9
Treatment of Iron Deficiency in Heart Failure	9
The Brain–Heart Axis: Neuroinflammatory Interactions in Cardiovascular Disease	9
Management of Atrial Fibrillation in the Emergency Department	9
Disparities in Cardio-oncology: Effects On Outcomes and Opportunities for Improvement	9
Keto is Trending: Implications for Body Weight and Lipid Management	8
Pregnancy-Associated Myocardial Infarction: A Review of Current Practices and Guidelines	8
Leadless Pacing: Where We Currently Stand and What the Future Holds	8
Artificial Intelligence to Improve Risk Prediction with Nuclear Cardiac Studies	8
Can Sound Public Health Policies Stem the Tide of Burgeoning Epidemic of Cardiovascular Disease in South Asians?	8
Novel Nutritional and Dietary Approaches to Weight Loss for the Prevention of Cardiovascular Disease: Ketogenic Diet, Intermittent Fasting, and Bariatric Surgery	8

The Role of Stress Echocardiography in Valvular Heart Disease	8
New Insights into the Role of Visit-to-Visit Glycemic Variability and Blood Pressure Variability in Cardiovascular Disease Risk	8
Mechanisms of Sarcomere Protein Mutation-Induced Cardiomyopathies	8
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia	8
Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes	8
Update on Minimalist TAVR Care Pathways: Approaches to Care in 2022	8
New Way to “SCORE” Risk: Updates on the ESC Scoring System and Incorporation into ESC Cardiovascular Prevention Guidelines	8
Atrioventricular Septal Defects: Pathology, Imaging, and Treatment Options	8
Current and Future Applications of Artificial Intelligence in Cardiac CT	8
The Potential of Fibroblast Activation Protein-Targeted Imaging as a Biomarker of Cardiac Remodeling and Injury	8
Role of Sex in Atherosclerosis: Does Sex Matter?	8
Direct Oral Anticoagulant Use in Special Populations: Elderly, Obesity, and Renal Failure	8
Posttraumatic Stress Disorder as a Consequence of Acute Cardiovascular Disease	7
Pericardiectomy and Pericardial Window for the Treatment of Pericardial Disease in the Contemporary Era	7
Invasive Hemodynamic Evaluation of the Fontan Circulation: Current Day Practice and Limitations	7
Treatment of Bicuspid Aortic Valve Stenosis with TAVR: Filling Knowledge Gaps Towards Reducing Complications	7
Beyond Statins and PCSK9 Inhibitors: Updates in Management of Familial and Refractory Hypercholesterolemias	7
Caregiver Distress and Coronary Artery Disease: Prevalence, Risk, Outcomes, and Management	7
MicroRNAs and Cardiovascular Disease Risk	7
A Roadmap to Heart Regeneration Through Conserved Mechanisms in Zebrafish and Mammals	7
Chronic Thromboembolic Pulmonary Hypertension: the Bedside	7
Artificial Intelligence and Machine Learning Applications in Sudden Cardiac Arrest Prediction and Management: A Comprehensive Review	7
Body Fat Distribution, Diabetes Mellitus, and Cardiovascular Disease: an Update	7
Role of Catheter Ablation for Ventricular Arrhythmias in Brugada Syndrome	7
PET Imaging of Post-infarct Myocardial Inflammation	7
Multimodality Imaging of Myocardial Viability	7
Primary Aldosteronism: a Continuum from Normotension to Hypertension	7
Updates in the Impact of Chronic Systemic Inflammation on Vascular Inflammation by Positron Emission Tomography (PET)	7
Nuclear Imaging for the Assessment of Cardiotoxicity from Chemotherapeutic Agents in Oncologic Disease	7
Genetic Engineering of Donor Pig for the First Human Cardiac Xenotransplantation: Combatting Rejection, Coagulopathy, Inflammation, and Excessive Growth	7
INTERASPIRE: an International Survey of Coronary Patients; Their Cardiometabolic, Renal and Biomarker Status; and the Quality of Preventive Care Delivered in All WHO Regions	7
Current Status of Catheter-based Mitral Valve Replacement	7
Aspirin, Statins, and Primary Prevention: Opportunities for Shared Decision Making in the Face of Uncertainty	7
The Price of Progress: Cost, Access, and Adoption of Novel Cardiovascular Drugs in Clinical Practice	7
SGLT-2 Inhibitors in Heart Failure: Guide for Prescribing and Future Perspectives	7